EP3677674C0 - Transaminase mutant and use thereof - Google Patents
Transaminase mutant and use thereofInfo
- Publication number
- EP3677674C0 EP3677674C0 EP17930421.7A EP17930421A EP3677674C0 EP 3677674 C0 EP3677674 C0 EP 3677674C0 EP 17930421 A EP17930421 A EP 17930421A EP 3677674 C0 EP3677674 C0 EP 3677674C0
- Authority
- EP
- European Patent Office
- Prior art keywords
- transaminase mutant
- transaminase
- mutant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000003929 Transaminases Human genes 0.000 title 1
- 108090000340 Transaminases Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1096—Transferases (2.) transferring nitrogenous groups (2.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/001—Amines; Imines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
- C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12Y203/01001—Amino-acid N-acetyltransferase (2.3.1.1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2017/109500 WO2019084950A1 (en) | 2017-11-06 | 2017-11-06 | Transaminase mutant and use thereof |
Publications (4)
Publication Number | Publication Date |
---|---|
EP3677674A1 EP3677674A1 (en) | 2020-07-08 |
EP3677674A4 EP3677674A4 (en) | 2020-08-05 |
EP3677674B1 EP3677674B1 (en) | 2023-10-04 |
EP3677674C0 true EP3677674C0 (en) | 2023-10-04 |
Family
ID=66332012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17930421.7A Active EP3677674B1 (en) | 2017-11-06 | 2017-11-06 | Transaminase mutant and use thereof |
Country Status (4)
Country | Link |
---|---|
US (1) | US11407982B2 (en) |
EP (1) | EP3677674B1 (en) |
JP (1) | JP7022819B2 (en) |
WO (1) | WO2019084950A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021077425A1 (en) * | 2019-10-25 | 2021-04-29 | 凯莱英医药化学(阜新)技术有限公司 | Transaminase mutant and use thereof |
CN111117979B (en) * | 2020-01-14 | 2020-08-21 | 中国科学院苏州生物医学工程技术研究所 | Transaminase mutant, enzyme preparation, recombinant vector, recombinant cell and preparation method and application thereof |
CN115873819B (en) * | 2023-01-05 | 2023-05-02 | 山东省计算中心(国家超级计算济南中心) | D-amino acid transaminase mutant obtained based on super calculation assistance and application thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7202070B2 (en) * | 2000-10-31 | 2007-04-10 | Biocatalytics, Inc. | Method for reductive amination of a ketone using a mutated enzyme |
US8932836B2 (en) | 2010-08-16 | 2015-01-13 | Codexis, Inc. | Biocatalysts and methods for the synthesis of (1R,2R)-2-(3,4-dimethoxyphenethoxy)cyclohexanamine |
KR20160089492A (en) | 2013-11-26 | 2016-07-27 | 아심켐 래보러토리즈 (톈진) 컴퍼니, 리미티드 | Omega-transaminase of r configuration and use thereof |
CN105018440B (en) | 2014-04-24 | 2018-06-05 | 上海弈柯莱生物医药科技有限公司 | A kind of transaminase and its application in sitagliptin intermediate is synthesized |
KR101869432B1 (en) * | 2015-04-08 | 2018-06-20 | 연세대학교 산학협력단 | Omega-transaminase mutants with activity improvements toward ketones and methods for producing optically pure amines |
MX2017013136A (en) * | 2015-04-16 | 2018-02-21 | Hoffmann La Roche | Mutant transaminases as well as methods and uses relating thereto. |
CN105441403B (en) * | 2015-12-08 | 2018-07-31 | 上海工业生物技术研发中心 | Transaminase for producing C4H9NO2 |
-
2017
- 2017-11-06 EP EP17930421.7A patent/EP3677674B1/en active Active
- 2017-11-06 US US16/756,649 patent/US11407982B2/en active Active
- 2017-11-06 JP JP2020515646A patent/JP7022819B2/en active Active
- 2017-11-06 WO PCT/CN2017/109500 patent/WO2019084950A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2020537504A (en) | 2020-12-24 |
EP3677674B1 (en) | 2023-10-04 |
EP3677674A1 (en) | 2020-07-08 |
EP3677674A4 (en) | 2020-08-05 |
US20210024904A1 (en) | 2021-01-28 |
WO2019084950A1 (en) | 2019-05-09 |
US11407982B2 (en) | 2022-08-09 |
JP7022819B2 (en) | 2022-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL273236A (en) | Pyrazolopyrimidinone compounds and uses thereof | |
IL293377B1 (en) | Hsd17b13 variants and uses thereof | |
GB2582410B (en) | DDX24 mutations and use thereof | |
GB201714745D0 (en) | New compounds and uses | |
HK1244512A1 (en) | Mutant smoothened and methods of using the same | |
GB201714740D0 (en) | New compounds and uses | |
IL262846A (en) | Cd200 mutant and its uses | |
GB201714734D0 (en) | New compounds and uses | |
IL277502A (en) | Compounds and uses thereof | |
SG11202008543RA (en) | Pyrrolidineamide derivatives and uses thereof | |
IL279483A (en) | Cyanotriazole compounds and uses thereof | |
EP3712262A4 (en) | Transaminase mutant and application thereof | |
GB2563869B (en) | Materials and methods | |
GB201714736D0 (en) | New compounds and uses | |
EP3677674C0 (en) | Transaminase mutant and use thereof | |
IL267937A (en) | Amide compounds and use thereof | |
IL265531A (en) | N 3 -cyclically substituted thienouraciles and use thereof | |
IL269836B (en) | Substituted n-arylethyl-2-aminoquinoline-4-carboxamides and use thereof | |
GB201801102D0 (en) | New compounds and uses | |
GB201712110D0 (en) | New compounds and uses | |
IL280369A (en) | New myokines and uses thereof | |
IL269843B (en) | Substituted n-arylethyl-2-arylquinoline-4-carboxamides and use thereof | |
GB201812776D0 (en) | New methods and uses | |
GB201902266D0 (en) | New methods and uses | |
GB201808427D0 (en) | Oral devices and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20200331 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20200706 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12N 15/63 20060101ALI20200630BHEP Ipc: C12N 9/10 20060101AFI20200630BHEP Ipc: C12N 15/54 20060101ALI20200630BHEP Ipc: C12P 13/00 20060101ALI20200630BHEP |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20210618 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20230509 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602017075080 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
U01 | Request for unitary effect filed |
Effective date: 20231018 |
|
U07 | Unitary effect registered |
Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI Effective date: 20231025 |
|
U20 | Renewal fee paid [unitary effect] |
Year of fee payment: 7 Effective date: 20231120 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240105 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240204 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231004 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240204 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240105 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231004 |